The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

Authors

  • N. Matikainen,

    1. Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
    2. Division of Cardiology, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
    Search for more papers by this author
  • M.-R. Taskinen

    1. Division of Cardiology, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
    Search for more papers by this author

No abstract is available for this article.

Ancillary